Hemorrhoids (Grade II-III, Symptomatic)
Investigational use for symptomatic relief of grade II-III internal/external hemorrhoidal disease; does not address anatomic prolapse.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for hemorrhoids. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use for hemorrhoidal symptoms is investigational.
- What evidence exists?
- Tier C (investigational). One small case series (Mukherjee 2018, n=30) reports short-term symptomatic improvement of grade II-III hemorrhoids after a single-session perianal application. There are no randomized controlled trials. Critical safety boundary: leeches must NEVER be placed inside the anal canal. Definitive treatments (rubber-band ligation, sclerotherapy, hemorrhoidectomy, fiber/hydration) remain standard of care; grade IV hemorrhoids require surgical referral.
- Main risks
- Bleeding from bite sites for 6 to 24 hours after detachment (anatomically near rectal bleeding sources — distinguish from hemorrhoidal bleeding)
- Bruising and tenderness in the perianal area for 5 to 10 days
- Itching at bite sites
- Local skin infection or, rarely, Aeromonas infection (heightened concern given perianal location)
- Allergic reaction to leech saliva (uncommon)
- Worsening pain or anal discomfort for 1 to 3 days after the session
- Small permanent scars at bite sites
- Catastrophic bleeding if leech is mistakenly placed intra-anally (NEVER do this)
- Who should not consider this
- Patients on blood thinners (warfarin INR >2.0, DOACs, heparin)
- Patients with hemophilia or other bleeding disorders
- Patients with severe anemia (Hb <10 g/dL)
- Patients with grade IV (irreducible) hemorrhoids — need surgical referral
- Patients with active perianal abscess or fissure
- Patients with inflammatory bowel disease and active proctitis
- Patients with HIV, diabetes, or immunosuppression (higher infection risk)
- What to ask your clinician
- Have I been evaluated by a colorectal surgeon, and is my hemorrhoid grade appropriate for this?
- Have I been worked up for other causes of rectal bleeding (colonoscopy when indicated)?
- What evidence supports leech therapy for hemorrhoids specifically?
- What is the practitioner's experience and Aeromonas-prevention plan in this region?
- How will leeches be kept extra-anal?
- What is the realistic chance of benefit, and for how long?
- What is the cost, and what does it commit me to?
- When to seek urgent care
- Heavy or persistent rectal bleeding, especially soaking through pads or causing dizziness
- Severe perianal pain, spreading redness, or pus (perianal abscess or cellulitis)
- Fever above 38.0 C / 100.4 F or chills
- Bleeding from a bite site lasting more than 24 to 48 hours
- Hives, throat tightness, or breathing difficulty
What this does NOT mean
- This is not FDA-cleared for hemorrhoids.
- A single 30-patient series is not evidence of efficacy or long-term benefit in the general population.
- Symptomatic relief does NOT correct hemorrhoidal anatomy — recurrence is expected.
- Leech therapy is not a substitute for colorectal evaluation, especially with bleeding.
- Mechanism rationale does NOT establish clinical efficacy versus standard treatments.
Safety cross-references
Clinical Profile
- Category
- gastrointestinal
- ICD-10
- K64.0, K64.1, K64.2, K64.8
- Safety tier
- medium
Evidence Summary
No controlled clinical trial or case series of leech therapy for hemorrhoids has been published; use is investigational and based on mechanistic reasoning (local decongestion and anti-inflammatory effects of salivary peptides) rather than clinical outcome data. Critical safety note: if leeches are used at all, they must be placed perianally and NEVER inside the anal canal, where there is significant bleeding and abscess risk. Grade IV (irreducible prolapse) requires surgical referral. Given the absence of any supporting evidence, leech therapy has no established role and should be regarded, at most, as an unproven interim symptomatic measure.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)
Key Trials
- Mukherjee SK (2018), n=30
Detailed Trial Entries
1 trial indexed in the ASH RCT Library with full Study Profile, GRADE rating, and clinical implications:
Contraindications
- Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
- Hemophilia or other bleeding disorder
- Severe anemia (Hb <10 g/dL)
- Active bacteremia or sepsis
- Known hypersensitivity to leech salivary proteins
- Pregnancy (relative — first/third trimester)
- Immunocompromised state with severe neutropenia
- Grade IV (irreducible) hemorrhoids — surgical referral
- Active perianal abscess or fissure
- Inflammatory bowel disease with active proctitis
Related Conditions
External Thrombosed Hemorrhoid (Acute, <72h)
Investigational adjunct for acute external thrombosed hemorrhoids presenting within 72 hours; distinct from internal hemorrhoidal disease.
Chronic Anal Fissure (>8 Weeks)
Investigational adjunct for chronic anal fissure refractory to medical therapy; very limited case-report evidence; surgical sphincterotomy remains gold standard.
Non-Alcoholic Fatty Liver Disease (Investigational Adjunct)
Investigational adjunct in NAFLD/MASLD; small case series only; weight loss, dietary modification, and resmetirom remain primary.
Hepatic Portal Congestion (Non-Cirrhotic, Investigational)
Highly investigational adjunct for non-cirrhotic hepatic congestion; case reports only; cirrhosis and portal hypertension are absolute exclusions.